Jan Møller Mikkelsen

Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma Nordics A/S, VELOXIS PHARMACEUTICALS A/S, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma Nordics A/S, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

MAXYGEN ApS, PROFOUND INVEST A/S, PROFOUND INVEST A/S, HYSCITE DISCOVERY A/S, NORDIC BIOTECH INCENTIVE ApS